Traditional vaccines take many years to develop. A recent innovation in vaccine technology involves exploitation of messenger RNA, or mRNA, to facilitate rapid scaling of vaccines and expedite their modification if the virus mutates significantly. The Pfizer and Moderna COVID-19 vaccines capitalize on this technology to induce antibody production against the SARS-CoV-2 virus.
In this episode, we discuss:
In this episode, we discuss:
- (00:00) Introduction
- (01:31) The difference between the mRNA and traditional vaccines
- (06:29) Real vaccine side effects known to exist (and why Dr. Seheult believes that the benefits outweigh the risk)
The Aliquot Preview näytetään tässä palvelussa avoimen RSS-syötteen kautta. RSS-syötteen tiedostot, kuvaukset, kansikuvat ja muu metadata ovat podcastin omistajan omaisuutta, eivätkä ole yhteydessä Podplayn kanssa.